Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial
Year: 2008
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Philip C. Amrein, Eyal Attar, Tak Takvorian, Ephraim Hochberg, Karen K. Ballen, Kathleen M. Leahy, Donna Neuberg, Jennifer R. Brown
Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2490049330